Anti-TRA-1-60 MicroBeads, human

Anti-TRA-1-60 MicroBeads, human

The direct Anti-TRA-1-60 MicroBeads and the indirect Anti-TRA-1-60 MicroBead Kit have been developed for the positive selection of human pluripotent stem cells based on the expression of the TRA-1-60 antigen.
The direct Anti-TRA-1-60 MicroBeads offer a 10 min isolation procedure, minimizing cell handling time.

Background information

The Anti-TRA-1-60 monoclonal antibody reacts with a pluripotent stem cell–specific antigen expressed on undifferentiated human embryonic stem (ES) cells, induced pluripotent (iPS) cells, embryonal carcinoma (EC) cells, and embryonic germ (EG) cells.
The expression of TRA-1-60 on human ES cells is down-regulated upon differentiation. The Anti-TRA-1-60 antibody recognizes a neuraminidase-resistant carbohydrate epitope expressed on podocalyxin, a member of the CD34-related family of sialomucins. Podocalyxin is a transmembrane glycoprotein, which has been implicated in the development of aggressiveness in a variety of cancers including breast cancer and prostate cancer.


  • Positive selection of undifferentiated TRA-1-60+ pluripotent stem cells, for example, human ES and iPS cells.
  • Efficient enrichment of iPS cells during or after reprogramming1,5 .


MS or autoMACS
Columns for use with Anti-TRA-1-60 MicroBeads.
LS or autoMACS Columns for use with the Anti-TRA-1-60 MicroBead Kit.
Product options: 2
up to
total cells
EUR 651,00 
for 2×
total cells
EUR 628,00 

Related products

8 products available | view all